While reporting its financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) forecast fiscal 2021 revenues in a range of $16.4 billion to $16.8 billion, and adjusted earnings per share in a range of $2.50 to $2.70. This compares to revenues of $16.7 billion and adjusted earnings per share of $2.57 per share for fiscal 2020.

Create Account

Dark

chart

exchange

RTTNews | Feb 10, 2021 07:17AM EST

07:16 Wednesday, February 10, 2021 (RTTNews.com) - While reporting its financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) forecast fiscal 2021 revenues in a range of $16.4 billion to $16.8 billion, and adjusted earnings per share in a range of $2.50 to $2.70. This compares to revenues of $16.7 billion and adjusted earnings per share of $2.57 per share for fiscal 2020.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.63 per share for the year on revenues of $16.76 billion. Analysts' estimates typically exclude special items.

Read the original article on RTTNews ( https://www.rttnews.com/3168577/teva-pharma-projects-fy21-earnings-in-line-with-estimates-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved